India Stays Exclusive Marketing Rights For Eli Lilly's Cialis
The Indian patent office has stayed the exclusive marketing rights (EMR) for Eli Lilly's anti-impotence drug Cialis, raising fresh doubts about the system that was meant as a temporary measure to...To view the full article, register now.
Already a subscriber? Click here to view full article